Abiopharma

Barings BDC Inc is a US-based specialty finance company. Its core business is to provide customized finance to lower middle-market companies primarily in the United States. The companys investment objective is to seek attractive returns by generating current income from debt investments and capital appreciation from equity related investments. It invests in high yield subordinated debt securities secured by second lien security interests in portfolio company assets, coupled with equity instruments of privately held companies as well as in senior secured debt which is restricted to a certain limit. It generates revenues in the form of interest income, primarily from investments in debt securities, and loan origination.

Additional info from NASDAQ:
Barings Corporate Investors MCI seeks to provide a consistent yield while at the same time offering an opportunity for capital gains. Fund invests principally in privately placed, below-investment grade, long-term debt obligations and often accompanied by equity features, purchased directly from their issuers and sourced through Barings extensive deal network of private equity sponsors.

Additional info from NASDAQ:
Barings Participation Investors investment objective is to maximize total return by providing a high level of current income the potential for income growth and capital appreciation. Fund invests primarily in privately placed, below-investment grade debt obligations purchased directly from their issuers and often accompanied by equity features, with additional allocations to publicly traded debt securities, including high yield securities.

Additional info from NASDAQ:
Barings BDC Inc is a US-based specialty finance company. Its core business is to provide customized finance to lower middle-market companies primarily in the United States. The companys investment objective is to seek attractive returns by generating current income from debt investments and capital appreciation from equity related investments. It invests in high yield subordinated debt securities secured by second lien security interests in portfolio company assets, coupled with equity instruments of privately held companies as well as in senior secured debt which is restricted to a certain limit. It generates revenues in the form of interest income, primarily from investments in debt securities, and loan origination.